Tuberculin Purified Protein Derivative (National Heart, Lung, And Blood Institute)
结核菌素纯蛋白衍生物（National Heart, Lung, and Blood Institute (NHLBI)）
Report date: 2022/12/31 17:30:02
Base Information
Drug NameTuberculin Purified Protein Derivative (National Heart, Lung, And Blood Institute)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
China Registration ClassN/A
Develop Information
Active CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksDrugBank